FDA Permits Marketing of Hemospray Device for Treating Gastrointestinal Bleeding

FDA Permits Marketing of Hemospray Device for Treating Gastrointestinal Bleeding

Source: 
CP Wire
snippet: 
The U.S. Food and Drug Administration announced on 5/7/18 that it has permitted marketing of Hemospray, by Wilson-Cook Medical Inc., a new device used to help control certain types of bleeding in the gastrointestinal (GI) tract.